๐ Eli Lilly $LLY climbs ~5% as EPS beats by $2.37 and revenue explodes +48% to $23B
Lilly crushed Q2 expectations with EPS of $8.38 โ $2.37 above the FactSet consensus โ and revenue of $22.97 billion, up 47.7% year-over-year. Weight-loss and diabetes drugs are still firing on all cylinders, making LLY one of the most powerful growth stories in pharma right now. Not financial advice. With nearly 50% revenue growth, does Lilly still have room to run from here?
โก 60 buzzing
774 views
๐ 0 subscribed